Literature DB >> 24763416

Midbrain-hindbrain involvement in septo-optic dysplasia.

M Severino1, A E M Allegri2, A Pistorio3, B Roviglione4, N Di Iorgi2, M Maghnie2, A Rossi5.   

Abstract

BACKGROUND AND
PURPOSE: Midbrain-hindbrain involvement in septo-optic dysplasia has not been well described, despite reported mutations of genes regulating brain stem patterning. We aimed to describe midbrain-hindbrain involvement in patients with septo-optic dysplasia and to identify possible clinical-neuroimaging correlations.
MATERIALS AND METHODS: Using MR imaging, we categorized 38 patients (21 males) based on the presence (group A, 21 patients) or absence (group B, 17 patients) of visible brain stem anomalies. We measured height and anteroposterior diameter of midbrain, pons, and medulla, anteroposterior midbrain/pons diameter (M/P ratio), vermian height, and tegmento-vermian angle, and compared the results with 114 healthy age-matched controls. Furthermore, patients were subdivided based on the type of midline anomalies. The associations between clinical and neuroradiological features were investigated. Post hoc tests were corrected according to Bonferroni adjustment (pB).
RESULTS: Patients with brain stem abnormalities had smaller anteroposterior pons diameter than controls (pB < .0001) and group B (pB = .012), higher M/P ratio than controls (pB < .0001) and group B (pB < .0001), and smaller anteroposterior medulla diameter (pB = .001), pontine height (pB = .00072), and vermian height (pB = .0009) than controls. Six of 21 patients in group A had thickened quadrigeminal plate, aqueductal stenosis, and hydrocephalus; 3 also had agenesis of the epithalamus. One patient had a short midbrain with long pons and large superior vermis. There was a statistically significant association between brain stem abnormalities and callosal dysgenesis (P = .011) and developmental delay (P = .035), respectively.
CONCLUSION: Midbrain-hindbrain abnormalities are a significant, albeit underrecognized, component of the septo-optic dysplasia spectrum, and are significantly associated with developmental delay in affected patients.
© 2014 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2014        PMID: 24763416      PMCID: PMC7964443          DOI: 10.3174/ajnr.A3959

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  42 in total

Review 1.  Isthmus organizer and regionalization of the mesencephalon and metencephalon.

Authors:  Harukazu Nakamura; Yuji Watanabe
Journal:  Int J Dev Biol       Date:  2005       Impact factor: 2.203

2.  Expression of the homeobox genes OTX2 and OTX1 in the early developing human brain.

Authors:  Karen B Larsen; Melissa C Lutterodt; Kjeld Møllgård; Morten Møller
Journal:  J Histochem Cytochem       Date:  2010-03-30       Impact factor: 2.479

3.  OTX2 microphthalmia syndrome: four novel mutations and delineation of a phenotype.

Authors:  K F Schilter; A Schneider; T Bardakjian; J-F Soucy; R C Tyler; L M Reis; E V Semina
Journal:  Clin Genet       Date:  2011-02       Impact factor: 4.438

Review 4.  Del(14)(q22.1q23.2) in a patient with anophthalmia and pituitary hypoplasia.

Authors:  E Lemyre; N Lemieux; J C Décarie; M Lambert
Journal:  Am J Med Genet       Date:  1998-05-01

5.  Septo-optic dysplasia: MR imaging.

Authors:  A J Barkovich; E K Fram; D Norman
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

6.  OTX2 loss of function mutation causes anophthalmia and combined pituitary hormone deficiency with a small anterior and ectopic posterior pituitary.

Authors:  Toshihiro Tajima; Akira Ohtake; Masaya Hoshino; Shin Amemiya; Nozomu Sasaki; Katsura Ishizu; Kenji Fujieda
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

7.  MRI in children with mental retardation.

Authors:  Gustavo Soto-Ares; Béatrice Joyes; Marie-Pierre Lemaître; Louis Vallée; Jean-Pierre Pruvo
Journal:  Pediatr Radiol       Date:  2003-03-11

8.  The duration of Fgf8 isthmic organizer expression is key to patterning different tectal-isthmo-cerebellum structures.

Authors:  Tatsuya Sato; Alexandra L Joyner
Journal:  Development       Date:  2009-09-30       Impact factor: 6.868

Review 9.  Otx genes in brain morphogenesis.

Authors:  D Acampora; M Gulisano; V Broccoli; A Simeone
Journal:  Prog Neurobiol       Date:  2001-05       Impact factor: 11.685

10.  Auditory interhemispheric transfer deficits, hearing difficulties, and brain magnetic resonance imaging abnormalities in children with congenital aniridia due to PAX6 mutations.

Authors:  Doris-Eva Bamiou; Samantha L Free; Sanjay M Sisodiya; Wui K Chong; Frank Musiek; Kathleen A Williamson; Veronica van Heyningen; Anthony T Moore; David Gadian; Linda M Luxon
Journal:  Arch Pediatr Adolesc Med       Date:  2007-05
View more
  4 in total

Review 1.  Advances in differential diagnosis and management of growth hormone deficiency in children.

Authors:  Camille Hage; Hoong-Wei Gan; Anastasia Ibba; Giuseppa Patti; Mehul Dattani; Sandro Loche; Mohamad Maghnie; Roberto Salvatori
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330

2.  Expanding the spectrum of congenital anomalies of the diencephalic-mesencephalic junction.

Authors:  Mariasavina Severino; Domenico Tortora; Angela Pistorio; Luca Antonio Ramenghi; Flavia Napoli; Maria Margherita Mancardi; Pasquale Striano; Valeria Capra; Andrea Rossi
Journal:  Neuroradiology       Date:  2015-10-07       Impact factor: 2.804

Review 3.  Midbrain-Hindbrain Boundary Morphogenesis: At the Intersection of Wnt and Fgf Signaling.

Authors:  Holly C Gibbs; Ana Chang-Gonzalez; Wonmuk Hwang; Alvin T Yeh; Arne C Lekven
Journal:  Front Neuroanat       Date:  2017-08-03       Impact factor: 3.856

Review 4.  Important Tools for Use by Pediatric Endocrinologists in the Assessment of Short Stature

Authors:  José I. Labarta; Michael B. Ranke; Mohamad Maghnie; David Martin; Laura Guazzarotti; Roland Pfäffle; Ekaterina Koledova; Jan M. Wit
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.